H
HeyPsych
PsychTrails™TreatmentsConditionsResourcesPsychiatristsAbout

Stay updated on mental health treatments

Get the latest research, treatment updates, and evidence-based insights delivered to your inbox. No spam, just valuable mental health information.

Coming Soon

Newsletter subscription will be available soon.

H
HeyPsych

Evidence-based mental health treatment education platform. Helping you make informed decisions about your mental health journey.

Treatments

  • Medications
  • Interventional
  • Investigational
  • Alternative
  • Therapy
  • Supplements

Conditions

  • Depression
  • Anxiety
  • ADHD
  • Bipolar
  • All Conditions

Resources

  • Assessments & Screeners
  • Support & Community
  • Digital Tools
  • Knowledge Hub
  • PsychTrails™

Company

  • About Us
  • Privacy Policy
  • Terms of Service
  • Contact

© 2026 HeyPsych (PsychTrails™). All rights reserved.

Made with for better mental health
v2.2.0

Closed-Loop Neurostimulation

Reviewed by the HeyPsych Medical Review Board

Board-certified psychiatrists and mental health professionals

Indications

Primary Indications

FDA-approved for drug-resistant epilepsyInvestigational for depression, Parkinson’s, chronic pain, Tourette syndrome

Mechanism

Closed-loop systems record neural signals (e.g., EEG, LFPs) and use algorithms to detect pathological patterns. When abnormal activity is identified, stimulation is automatically delivered to disrupt or normalize activity. This feedback-based mechanism enhances precision and reduces unnecessary stimulation.

Protocol

Preparation

Comprehensive neurological and psychiatric assessment, neuroimaging, surgical planning.

Procedure

  1. Surgical implantation of electrodes and neurostimulator
  2. Postoperative device programming
  3. Continuous monitoring of neural activity
  4. Adaptive stimulation delivered automatically

Frequency: Continuous real-time monitoring and intervention

Duration: Device lifespan 5–10 years (replaceable battery/generator)

Total Treatment Time: Long-term or lifelong therapy depending on condition

Equipment

  • Implantable neurostimulator
  • Electrodes (cortical, subcortical, or spinal depending on indication)
  • Programming console
  • Patient monitoring system

Session Structure

pre session: Baseline evaluation and device implantation

activation phase: Device programming and calibration

monitoring phase: Continuous closed-loop operation

post session: Regular follow-ups for adjustment and safety checks

Expected Outcomes

Immediate

  • Responsive suppression of pathological activity (e.g., seizures)

Short Term

  • Reduced symptom severity
  • Improved quality of life

Long Term

  • Potential disease course modification
  • Reduced medication dependence

Side Effects

common

  • Headache, dizziness after implantation

uncommon

  • Mood changes, device malfunction

rare

  • Infection, intracranial hemorrhage, hardware failure

Contraindications

absolute

  • Active systemic infection
  • Severe coagulopathy

relative

  • Poor surgical candidates
  • Nonadherence to follow-up

Patient Selection

ideal candidates

  • Adults with treatment-resistant epilepsy
  • Patients with severe movement disorders or depression unresponsive to conventional therapy

screening required

  • Neuroimaging
  • Neuropsychological evaluation
  • Surgical risk assessment

Training Requirements

practitioner

  • Functional neurosurgeon
  • Neurologist (epileptologist, movement disorder specialist)
  • Psychiatrist (for depression indications)

facility

  • Neurosurgical center with advanced neurotechnology capability

Research Evidence

studies

  • NeuroPace RNS System pivotal trials for epilepsy
  • Adaptive DBS trials in Parkinson’s (e.g., closed-loop STN stimulation)
  • Pilot studies in treatment-resistant depression

limitations: High cost, invasive procedure, limited to specialized centers.

Cost Considerations

typical session cost: N/A (continuous therapy)

total treatment cost: High (device + surgery $35,000–$70,000+)

insurance coverage: Available for FDA-approved epilepsy indication

cost effectiveness: Cost-effective for epilepsy in severe refractory cases; unknown for other indications

ux display: undefined

collapsible: undefined

heading: undefined

Integration Support

concurrent therapies

  • Antiepileptic drugs
  • Psychiatric medications
  • Physical therapy for motor disorders

lifestyle recommendations

  • Avoid activities with high seizure risk until stable
  • Adherence to follow-up monitoring

Special Populations

👶Pregnancy

Limited data; device safety during pregnancy not fully studied

Clinical Notes

  • Represents the next generation of neuromodulation beyond open-loop DBS.
  • Improves personalization and reduces side effects.
  • Likely to expand indications in the coming decade.

References

NeuroPace RNS System – FDA ApprovalAdaptive DBS in Parkinson’s Disease – Little et al., Nature Neuroscience 2013Closed-loop neuromodulation overview – Widge et al., Nature Biomedical Engineering 2019

This treatment information is for educational purposes only. Treatment decisions should be made in consultation with qualified healthcare professionals based on individual circumstances, symptoms, and medical history. Do not attempt treatment without professional guidance.

Interested in this treatment?

This information is for educational purposes. Always consult with a qualified healthcare provider before starting any new treatment.

Locate Psychiatrists